Search Results for: EGFR

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
PTPN6 protein tyrosine phosphatase non-receptor type 6
  • GPVI-mediated activation cascade
  • Regulation of KIT signaling
  • PECAM1 interactions
  • Costimulation by the CD28 family
  • PD-1 signaling
  • Signal regulatory protein family interactions
  • Platelet sensitization by LDL
  • Interleukin-3, Interleukin-5 and GM-CSF signaling
  • CD22 mediated BCR regulation
  • Neutrophil degranulation
  • Interferon gamma signaling
  • Regulation of IFNG signaling
  • Interleukin-37 signaling
  • Interferon alpha/beta signaling
  • Interleukin receptor SHC signaling
  • Regulation of IFNA signaling
  • Growth hormone receptor signaling
  • Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
  • Antigen activates B Cell Receptor (BCR) leading to generation of second messengers
  • Tiludronic acid
PTPN7 protein tyrosine phosphatase non-receptor type 7
  • Negative regulation of MAPK pathway
  • Interleukin-37 signaling
PTPRB protein tyrosine phosphatase receptor type B
  • Neutrophil degranulation
  • {4-[2-BENZYL-3-METHOXY-2-(METHOXYCARBONYL)-3-OXOPROPYL]PHENYL}SULFAMIC ACID
  • (4-{4-[(TERT-BUTOXYCARBONYL)AMINO]-2,2-BIS(ETHOXYCARBONYL)BUTYL}PHENYL)SULFAMIC ACID
  • {4-[2,2-BIS(5-METHYL-1,2,4-OXADIAZOL-3-YL)-3-PHENYLPROPYL]PHENYL}SULFAMIC ACID
  • (4-ETHYLPHENYL)SULFAMIC ACID
  • Razuprotafib
PTPRH protein tyrosine phosphatase receptor type H
PTPRJ protein tyrosine phosphatase receptor type J
  • Phosphorylation of CD3 and TCR zeta chains
  • Neutrophil degranulation
  • Negative regulation of MET activity
  • Negative regulation of FLT3
PTPRR protein tyrosine phosphatase receptor type R
PTPRS protein tyrosine phosphatase receptor type S
  • ECM proteoglycans
  • Receptor-type tyrosine-protein phosphatases
  • Synaptic adhesion-like molecules
  • Signaling by NTRK3 (TRKC)
  • Alendronic acid
  • Etidronic acid
PTPRT protein tyrosine phosphatase receptor type T
PTPRU protein tyrosine phosphatase receptor type U
  • Signaling by SCF-KIT
RAB31 RAB31, member RAS oncogene family
  • Neutrophil degranulation
  • RAB geranylgeranylation
  • RAB GEFs exchange GTP for GDP on RABs
RAB3A RAB3A, member RAS oncogene family
  • Serotonin Neurotransmitter Release Cycle
  • Norepinephrine Neurotransmitter Release Cycle
  • Glutamate Neurotransmitter Release Cycle
  • Dopamine Neurotransmitter Release Cycle
  • Acetylcholine Neurotransmitter Release Cycle
  • Neutrophil degranulation
  • RAB geranylgeranylation
  • RAB GEFs exchange GTP for GDP on RABs
  • GABA synthesis, release, reuptake and degradation
RAF1 Raf-1 proto-oncogene, serine/threonine kinase
  • Stimuli-sensing channels
  • Rap1 signalling
  • GP1b-IX-V activation signalling
  • CD209 (DC-SIGN) signaling
  • RAF activation
  • MAP2K and MAPK activation
  • Negative feedback regulation of MAPK pathway
  • Negative regulation of MAPK pathway
  • Signaling by moderate kinase activity BRAF mutants
  • Signaling by high-kinase activity BRAF mutants
  • Signaling by BRAF and RAF fusions
  • Paradoxical activation of RAF signaling by kinase inactive BRAF
  • Signaling downstream of RAS mutants
  • Signaling by RAF1 mutants
  • Signaling by MRAS-complex mutants
  • Sorafenib
  • LErafAON
  • XL281
  • iCo-007
  • Cholecystokinin
  • Regorafenib
  • Dabrafenib
  • Fostamatinib
RAP1GDS1 Rap1 GTPase-GDP dissociation stimulator 1
RAPGEF1 Rap guanine nucleotide exchange factor 1
  • Frs2-mediated activation
  • Frs2-mediated activation
  • Downstream signal transduction
  • MET activates RAP1 and RAC1
  • Erythropoietin activates RAS
  • Erythropoietin activates RAS
  • Regulation of signaling by CBL
RASA1 RAS p21 protein activator 1
  • Downstream signal transduction
  • EPHB-mediated forward signaling
  • EPHB-mediated forward signaling
  • VEGFR2 mediated cell proliferation
  • Regulation of RAS by GAPs
  • PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases
  • RASA1-related disorders, including: Parkes-Weber slndrome; Capillary malformation-arteriovenous malformation (CM-AVM); Arteriovenous fistula (AVF)
RGS16 regulator of G protein signaling 16
  • G alpha (q) signalling events
  • G alpha (i) signalling events
  • G alpha (i) signalling events
  • G alpha (z) signalling events
RGS2 regulator of G protein signaling 2
  • G alpha (q) signalling events
RGS4 regulator of G protein signaling 4
  • G alpha (q) signalling events
  • G alpha (i) signalling events
  • G alpha (i) signalling events
  • G alpha (z) signalling events
RIN1 Ras and Rab interactor 1
  • RAB GEFs exchange GTP for GDP on RABs
RIN2 Ras and Rab interactor 2
  • RAB GEFs exchange GTP for GDP on RABs
  • Macrocephaly, alopecia, cutis laxa, and scoliosis; MACS syndrome

Page 15 out of 21 pages